Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
(5R)-3-[3-fluoro-4-(3-hydroxyazetidin-1-yl)phenyl]-5-(isoxazol-3-yloxymethyl)oxazolidin-2-one → 3-(3-Fluoro-4-(2-methyl-imidazol-1-yl)phenyl)-5(r)-(isoxazol-3-yloxymethyl)oxazolidin-2-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | (5R)-3-[3-fluoro-4-(3-hydroxyazetidin-1-yl)phenyl]-5-(isoxazol-3-yloxymethyl)oxazolidin-2-one | HCID 497421 | — |
| 반응물 | (5R)-3-(3-Fluoro-4-(2-methylimidazol-1-yl)phenyl)-5-hydroxymethyloxazolidin-2-one | HCID 21356557 | — |
| 생성물 | 3-(3-Fluoro-4-(2-methyl-imidazol-1-yl)phenyl)-5(r)-(isoxazol-3-yloxymethyl)oxazolidin-2-one | HCID 69983189 | — |
반응 단계
Using essentially the same procedure as for the intermediate of Example 65, but starting with 3-(3-fluoro-4-(2-methyl-imidazol-1-yl)phenyl)-5(R)-hydroxymethyloxazolidin-2-one (202 mg, 0.69 mmol), and purifying by chromatography on a 10 g silica Mega Bond Elut® column, eluting with a gradient increasing in polarity from 0 to 2.5% MeOH in dichloromethane, the title compound was prepared (137 mg).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US06617339B1 |
| 출처 데이터셋 | uspto-grants-2003_09 |
| ORD ID | ord-ad97199a624f4a19942add03c6b27245 |
| 출처 메모 | uspto-grants-2003_09 |